Skip to main content

Five reasons we are positive on EM equities

Emerging markets, once seen as volatile, are now demonstrating strong fundamentals and macro discipline—offering not just diversification, but real opportunity, says Ygal Sebban, Investment Director, Emerging Markets Equities.

18 August 2025

Emerging markets (EMs) have long been perceived as vulnerable to country-specific risks. Today, however, I believe they are demonstrating stronger macroeconomic discipline and greater resilience, especially as developed markets (DMs) face mounting fiscal pressures and slowing growth. EMs are projected to contribute approximately 65% of global economic growth by 2035, with nine key EMs expected to rank among the world’s 20 largest economies1. Their fiscal health is notably stronger, with average government debt-to-GDP ratios just above 60%, compared to over 100% in DMs.2 This shift highlights the growing appeal of EM.

Following this year’s strong performance, my outlook remains unchanged: I continue to be optimistic and bullish on EM equities.

  1. Attractive valuations: a compelling entry point

Chart 1: MSCI EM price-to-earnings (PE) ratio discount to US equities

 
Source: GAM Investments, Bloomberg, MSCI, as at 11 August 2025.

EMs are rebounding after years of underperformance. Over the past decade, EM equities have lagged developed markets (DMs) by more than 50%3, but 2025 marks the beginning of a catch-up phase, both in performance and valuation. EM equities continue to trade at historically low levels, offering a compelling entry point compared to DMs, which remain richly valued.

Historically, EM valuation discounts have reflected slower growth expectations. Today, however, EMs are showing stronger growth momentum than DMs, yet this is not reflected in their pricing. The disconnect suggests significant upside potential, as current valuations fail to capture EMs’ improving fundamentals.

While EMs are diverse, most markets trade at deep discounts relative to their own history and global peers. India is the exception, with valuations slightly elevated versus its historical average—but not excessively stretched. Meanwhile, US equities continue to command a substantial premium, both relative to EMs and their own historical norms.

  1. China’s growth stimulus adds momentum

China remains a key driver of EM momentum, with GDP growth targeted at 5% in 2025.4 The first half of the year delivered strong performance, supported by robust exports—some front-loaded ahead of anticipated trade shifts. More importantly, growth is being actively stimulated through accommodative monetary and fiscal policy. Credit activity is picking up, and interest rates remain low, encouraging capital flows into equities and supporting broader expansion. While global trade risks persist, particularly around tariffs, the outlook is more balanced than feared. Trade tensions between the US and China also appear to be stabilising.

This backdrop reinforces the appeal of domestic and idiosyncratic themes within EM, in my view. A particularly supportive catalyst is the US Federal Reserve’s (Fed’s) rate-cutting cycle, which adds further momentum to EM assets. Taken together, these factors strengthen the case for continued optimism in EM.

  1. Fed rate cuts create tailwinds for EMs

Chart 2: MSCI EM vs DM, Fed funds and cut cycle

 
Source: GAM Investments, Bloomberg, MSCI, as at 11 August 2025.

Historically, EM equities have tended to outperform developed markets during Fed rate-cutting cycles. While there are exceptions, such as the Asian financial crisis and the Covid period marked by aggressive quantitative easing, the trend has generally held. With the Fed expected to begin cutting rates in September 2025, this cycle could once again act as a catalyst for EM outperformance. Lower US rates ease global financial conditions, giving EM central banks more flexibility to reduce their own rates. In fact, 17 out of 19 EM countries are already seeing rate cuts, which supports domestic growth and equity market performance.

This environment is particularly favourable for domestic and idiosyncratic EM stories, as lower rates stimulate credit, investment and consumer demand. Combined with improving fundamentals and attractive valuations, the Fed’s easing cycle adds another layer of support to the bullish case for EM.

  1. USD weakness supports EM performance

Chart 3: EM relative performance and USD in the long term

 
Source: GAM Investments, Bloomberg, MSCI, JP Morgan, as at 11 August 2025.

The expected weakening of the US dollar is another key catalyst for EMs. Historically, EM equities have shown a strong inverse correlation with the dollar, and with the Fed likely to begin cutting rates, downward pressure on the USD is set to continue. This trend is driven not only by monetary policy but also by concerns over the sustainability of US fiscal deficits, currently running at nearly USD 2 trillion annually, with almost USD 7 trillion in spending against about USD 5 trillion in revenue.5

A weaker dollar supports EM performance in several ways: it boosts trade competitiveness, attracts capital flows and strengthens EM currencies. Many EM countries also offer high real interest rates, further supporting the attractiveness of their currencies.

Valuations remain compelling. EM equities trade at a significant discount to US counterparts, even when adjusting for sector composition. Combined with stronger growth prospects, particularly in China, and supportive rate cycles, the macro backdrop could lead to EM outperformance.

In short, dollar weakness, attractive valuations and resilient fundamentals reinforce the long-term investment case for EM.

  1. Renewed investor inflows signal a turning point

After outflows for the year falling to USD 83 billion in 2024 from USD 132 billion in 20236, EM equities are beginning to see renewed investor interest. In recent months, approximately USD 31 billion has returned to EM equities, marking a potential turning point. This rebound comes as EM allocations remain significantly underweight in global portfolios, suggesting ample room for further inflows. This creates what many refer to as a “pain trade”; investors who missed the rally are now under pressure to re-enter as EMs continue to outperform. The setup is compelling, EM equities are attractively valued after years of lagging, interest rates are falling across both EMs and the US, and EM growth is outpacing that of DM.

Importantly, these fundamentals are not yet fully reflected in valuations. Combined with continued stimulus from China and a supportive macro backdrop, the case for EMs remains strong. EM are cheap, under-owned, and well-positioned for further upside.

A few words on tariffs

Despite headline concerns, the actual impact of tariffs on China’s equity market is minimal. Only around 3% of MSCI China earnings are tied to the US, and companies with high US exposure, such as PDD Holdings , are typically avoided. For major exporters like Taiwan and Korea, the outlook is more constructive. Taiwan has secured favourable terms with the US, including broad exemptions for semiconductor firms, and recent developments allow Nvidia to resume exports of advanced chips to China, highlighting the mutual interest in maintaining tech trade flows.

We remain cautious on countries more exposed to tariff risks, such as Mexico and smaller Asian exporters like Vietnam, Thailand, Philippines and Indonesia. Tariffs in these regions range from 19% to 30%, and complex supply chains, such as Chinese firms re-exporting via Vietnam, face higher scrutiny. This uncertainty limits the appeal of broad export plays, except in semiconductors and artificial intelligence (AI).

While tariffs may weigh on global growth, second-order effects are mitigated by China’s domestic stimulus and falling interest rates across EMs. These factors support domestic demand and reinforce the case for focusing on internally-driven EM stories.

A strong case for EMs

EMs are entering a new phase of opportunity, in my view. With improving macro fundamentals, attractive valuations, supportive policy cycles and renewed investor interest, EMs are well-positioned to outperform. As DMs face rising fiscal and political pressures, the resilience and dynamism of EMs stand out. For investors seeking growth, diversification and long-term value, EM offer a compelling proposition, driven by domestic demand, innovation and structural reform.



Ygal Sebban leads the Emerging Markets Equity team and manages the Emerging Markets Equity strategy at GAM Investments.

1Source: S&P Global, “Emerging Markets: A Decisive Decade”, 16 October 2024.
2Source: IMF Fiscal Monitor, as at December 2024.
3Source: MSCI as at 31 July 2025. 10-year gross USD return for MSCI EM Index vs MSCI World Investable Market Index (IMI) Index = 82.39% vs 179.75%.
4Source: BBC, “China targets 5% growth as it reels from Trump tariffs”, 4 March 2025.
5Source: US Department of the Treasury, Fiscal Data, as at 31 December 2024.
6Source: FitchRatings, “Emerging Market Capital Flows Weakened in 2024 but Should Recover Modestly in 2025”, as at 11 June 2025.

Ygal Sebban

Director de Inversiones
Mis reflexiones

Póngase en contacto con nosotros: nos encantaría conocer su opinión

Artículos Relacionados

Aprovechar las oportunidades en los mercados emergentes

Ygal Sebban

Listo para despegar - Conclusiones del Salón Aeronáutico de París 2025: Crece el optimismo en la cadena de suministro

Tom O'Hara

Historia de dos futuros económicos: El giro fiscal alemán frente a la espiral de déficit estadounidense

Tom O'Hara

Opiniones de inversión

Estrategias destacadas

Equity
Emerging Markets Equity

Important disclosures and information
The information contained herein is given for information purposes only and does not qualify as investment advice. Opinions and assessments contained herein may change and reflect the point of view of GAM in the current economic environment. No liability shall be accepted for the accuracy and completeness of the information contained herein. Past performance is no indicator of current or future trends. The mentioned financial instruments are provided for illustrative purposes only and shall not be considered as a direct offering, investment recommendation or investment advice or an invitation to invest in any GAM product or strategy. Reference to a security is not a recommendation to buy or sell that security. The securities listed were selected from the universe of securities covered by the portfolio managers to assist the reader in better understanding the themes presented. The securities included are not necessarily held by any portfolio or represent any recommendations by the portfolio managers. Specific investments described herein do not represent all investment decisions made by the manager. The reader should not assume that investment decisions identified and discussed were or will be profitable. Specific investment advice references provided herein are for illustrative purposes only and are not necessarily representative of investments that will be made in the future. No guarantee or representation is made that investment objectives will be achieved. The value of investments may go down as well as up. Investors could lose some or all of their investments.

The MSCI Emerging Markets Index captures large and mid cap representation across 24 Emerging Markets (EM) countries. With 1,202 constituents, the index covers approximately 85% of the free float-adjusted market capitalisation in each country. The MSCI USA Index is designed to measure the performance of the large and mid cap segments of the US market. With 544 constituents, the index covers approximately 85% of the free float-adjusted market capitalisation in the US. The MSCI Emerging Markets ex China Index captures large and mid cap representation across 23 of the 24 Emerging Markets (EM) countries* excluding China. With 644 constituents, the index covers approximately 85% of the free float-adjusted market capitalisation in each country. The MSCI USA Growth Index captures large and mid cap securities exhibiting overall growth style characteristics in the US. The growth investment style characteristics for index construction are defined using five variables: long-term forward EPS growth rate, short-term forward EPS growth rate, current internal growth rate and long-term historical EPS growth trend and long-term historical sales per share growth trend. (All as at 31 July 2025) References to indexes and benchmarks are hypothetical illustrations of aggregate returns and do not reflect the performance of any actual investment. Investors cannot invest in indices which do not reflect the deduction of the investment manager’s fees or other trading expenses. Such indices are provided for illustrative purposes only. Indices are unmanaged and do not incur management fees, transaction costs or other expenses associated with an investment strategy. Therefore, comparisons to indices have limitations. There can be no assurance that a portfolio will match or outperform any particular index or benchmark.This article contains forward-looking statements relating to the objectives, opportunities, and the future performance of the equity markets generally. Forward-looking statements may be identified by the use of such words as; “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of any particular investment strategy. All are subject to various factors, including, but not limited to general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting a portfolio’s operations that could cause actual results to differ materially from projected results. Such statements are forward-looking in nature and involve a number of known and unknown risks, uncertainties and other factors, and accordingly, actual results may differ materially from those reflected or contemplated in such forward-looking statements. Prospective investors are cautioned not to place undue reliance on any forward-looking statements or examples. None of GAM or any of its affiliates or principals nor any other individual or entity assumes any obligation to update any forward-looking statements as a result of new information, subsequent events or any other circumstances. All statements made herein speak only as of the date that they were made.

This disclosure shall in no way constitute a waiver or limitation of any rights a person may have under such laws and/or regulations.

In the United Kingdom, this material has been issued and approved by GAM London Ltd, 8 Finsbury Circus, London EC2M 7GB, authorised and regulated by the Financial Conduct Authority.